User profiles for Zev A. Binder
Zev A. BinderUniversity of Pennsylvania Verified email at pennmedicine.upenn.edu Cited by 3525 |
The genetic landscape of the childhood cancer medulloblastoma
Medulloblastoma (MB) is the most common malignant brain tumor of children. To identify the
genetic alterations in this tumor type, we searched for copy number alterations using high-…
genetic alterations in this tumor type, we searched for copy number alterations using high-…
[PDF][PDF] A patient-derived glioblastoma organoid model and biobank recapitulates inter-and intra-tumoral heterogeneity
Glioblastomas exhibit vast inter- and intra-tumoral heterogeneity, complicating the development
of effective therapeutic strategies. Current in vitro models are limited in preserving the …
of effective therapeutic strategies. Current in vitro models are limited in preserving the …
[HTML][HTML] Long interspersed element-1 protein expression is a hallmark of many human cancers
Cancers comprise a heterogeneous group of human diseases. Unifying characteristics
include unchecked abilities of tumor cells to proliferate and spread anatomically, and the …
include unchecked abilities of tumor cells to proliferate and spread anatomically, and the …
Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results
Recurrent glioblastoma (rGBM) remains a major unmet medical need, with a median overall
survival of less than 1 year. Here we report the first six patients with rGBM treated in a phase …
survival of less than 1 year. Here we report the first six patients with rGBM treated in a phase …
[PDF][PDF] Epidermal growth factor receptor extracellular domain mutations in glioblastoma present opportunities for clinical imaging and therapeutic development
We explored the clinical and pathological impact of epidermal growth factor receptor (EGFR)
extracellular domain missense mutations. Retrospective assessment of 260 de novo …
extracellular domain missense mutations. Retrospective assessment of 260 de novo …
[HTML][HTML] Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond …
The remarkable heterogeneity of glioblastoma, across patients and over time, is one of the
main challenges in precision diagnostics and treatment planning. Non-invasive in vivo …
main challenges in precision diagnostics and treatment planning. Non-invasive in vivo …
[HTML][HTML] The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomics
Glioblastoma is the most common aggressive adult brain tumor. Numerous studies have
reported results from either private institutional data or publicly available datasets. However, …
reported results from either private institutional data or publicly available datasets. However, …
[HTML][HTML] Checkpoint blockade reverses anergy in IL-13Rα2 humanized scFv-based CAR T cells to treat murine and canine gliomas
Y Yin, AC Boesteanu, ZA Binder, C Xu, RA Reid… - Molecular Therapy …, 2018 - cell.com
We generated two humanized interleukin-13 receptor α2 (IL-13Rα2) chimeric antigen
receptors (CARs), Hu07BBz and Hu08BBz, that recognized human IL-13Rα2, but not IL-13Rα1. …
receptors (CARs), Hu07BBz and Hu08BBz, that recognized human IL-13Rα2, but not IL-13Rα1. …
[PDF][PDF] Single-cell RNA-seq-based proteogenomics identifies glioblastoma-specific transposable elements encoding HLA-I-presented peptides
…, A Merlotti, M Carrascal, JV Zhang, E Zueva, ZA Binder… - Cell Reports, 2022 - cell.com
We analyze transposable elements (TEs) in glioblastoma (GBM) patients using a
proteogenomic pipeline that combines single-cell transcriptomics, bulk RNA sequencing (RNA-seq) …
proteogenomic pipeline that combines single-cell transcriptomics, bulk RNA sequencing (RNA-seq) …
Targeting PAK4 to reprogram the vascular microenvironment and improve CAR-T immunotherapy for glioblastoma
Malignant solid tumors are characterized by aberrant vascularity that fuels the formation of
an immune-hostile microenvironment and induces resistance to immunotherapy. Vascular …
an immune-hostile microenvironment and induces resistance to immunotherapy. Vascular …